Impact of wait times on survival for women with uterine cancer

Journal of Clinical Oncology

Volumn 32, Issue 1, 2014, Pages 27-33

  Elit, Lorraine M ^a   O'Leary, Erin M ^a   Pond, Gregory R ^a   Seow, Hsien Yeang ^a  

^a Escarpment Cancer Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CANCER; OMENTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TIME; UTERUS CANCER; WAIT TIME; AGED; CANADA; CARCINOMA, ENDOMETRIOID; ECONOMICS; EPIDEMIOLOGY; HOSPITAL ADMISSION; HYSTERECTOMY; INSURANCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; TIME TO TREATMENT; UTERINE NEOPLASMS; ENDOMETRIOID CARCINOMA;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; HYSTERECTOMY; INSURANCE COVERAGE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONTARIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; TIME-TO-TREATMENT; UTERINE NEOPLASMS; WAITING LISTS;

EID: 84894684263     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.3671     Document Type: Article

References (36)

1. Yun YH, Kim YA, Min YH, et al: The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731-2737, 2012
2. Brazda A, Estroff J, Euhus D, et al: Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol 17:291-296, 2010
3. Robinson KM, Christensen KB, Ottesen B, et al: Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: A nationwide Danish study. Qual Life Res 21:1519-1525, 2012
4. Dietsch E, Davies C: The nocebo effect for women in waiting. Collegian 14:9-14, 2007
5. Davies S: Diagnosis cancer: One woman's agonizing wait for surgery. Canadian Health. http://www.canadian-health.ca/2-5/42-e.html
6. Richards MA, Westcombe AM, Love SB, et al: Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353:1119-1126, 1999 (Pubitemid 29155203)
7. Simunovic M, Rempel E, Thériault ME, et al: Influence of delays to non-emergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg 52:E79-E86, 2009
8. Wait Times Alliance Canada: Reducing Wait Times and Achieving Benchmarks. Ottawa, ON, Canada, Canadian Medical Association, November 2006
9. Ayres BE, Gillatt D, McPhail S, et al: A delay in radical cystectomy of > 3 months is not associated with a worse clinical outcome. BJU Int 102:1045, 2008
10. Kulkarni GS, Urbach DR, Austin PC, et al: Longer wait times increase overall mortality in patients with bladder cancer. J Urol 182:1318-1324, 2009
11. Lee CT, Madii R, Daignault S, et al: Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175:1262-1267, 2006
12. Gore JL, Lai J, Setodji CM, et al: Mortality increases when radical cystectomy is delayed more than 12 weeks: Results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988-996, 2009
13. Pacifico MD, Pearl RA, Grover R: The UK Government two-week rule and its impact on melanoma prognosis: An evidence-based study. Ann R Coll Surg Engl 89:609-615, 2007 (Pubitemid 47408293)
14. Grotenhuis BA, van Hagen P, Wijnhoven BP, et al: Delay in diagnostic workup and treatment of esophageal cancer. J Gastrointest Surg 14:476-483, 2010
15. Kötz BS, Croft S, Ferry DR: Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer 95:835-840, 2006
16. Sharpe D, Williams RN, Ubhi SS, et al: The "two-week wait " referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J Surg Oncol 36:977-981, 2010
17. Currie AC, Evans J, Smith NJ, et al: The impact of the two-week wait referral pathway on rectal cancer survival. Colorectal Dis 14:848-853, 2012
18. Walsh SR, Gilson NL, Brown K, et al: Trends in colorectal cancer survival following the 2-week rule. Colorectal Dis 9:207-209, 2007 (Pubitemid 46477022)
19. Zafar A, Mak T, Whinnie S, et al: The 2-week wait referral system does not improve 5-year colorectal cancer survival. Colorectal Dis 14:e177-e180, 2012
20. Stec AA, Coons BJ, Chang SS, et al: Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma: Does it affect survival? J Urol 179:2152-2157, 2008
21. Symonds RP: Cancer biology may be more important than diagnostic delay. BMJ 325:774, 2002
22. Umezu T, Shibata K, Kajiyama H, et al: Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: Does the waiting time to the operation affect survival? Arch Gynecol Obstet 285:493-497, 2010
23. Reference deleted
24. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987 (Pubitemid 17055592)
25. Menczer J, Krissi H, Chetrit A, et al: The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol 173:774-778, 1995
26. Canadian Institute for Health Information: Waiting for Health Care in Canada: What We Know and What We Don't Know. Ottawa, ON, Canada, Canadian Institute for Health Information, 2006
27. Paterson JM, Hux JE, Tu JV, et al: The Ontario Wait Times Strategy: No Evidence of an Adverse Impact on Other Surgeries. Toronto, ON, Canada, Institute for Clinical Evaluative Sciences, 2007
28. Cancer Care Ontario, Action Cancer Ontario: Target Wait Times for Cancer Surgery in Ontario. Final Report, revised April 2006. https://www.cancercare.on. ca/common/pages/UserFile.aspx?fileId=43244
29. Kwon JS, Carey MS, Cook EF, et al: Addressing wait times for endometrial cancer surgery in Ontario. J Obstet Gynaecol Can 29:982-987, 2007
30. Stitzenberg KB, Sigurdson ER, Egleston BL, et al: Centralization of cancer surgery: Implications for patient access to optimal care. J Clin Oncol 27:4671-4678, 2009
31. Birkmeyer JD, Siewers AE, Marth NJ, et al: Regionalization of high-risk surgery and implications for patient travel times. JAMA 290:2703-2708, 2003 (Pubitemid 37475598)
32. Doss LL, Llorens AS, Henriquez EM: Carcinosarcoma of the uterus: A 40-year experience for the state of Missouri. Gynecol Oncol 18:43-53, 1984 (Pubitemid 14101345)
33. Truong PT, Kader HA, Lacy B, et al: The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer. Am J Clin Oncol 28:157-164, 2005
34. Guillén-Ponce C, Molina-Garrido MJ, Carrato A: Follow-up recommendations and risk-reduction initiatives for Lynch syndrome. Expert Rev Anticancer Ther 12:1359-1367, 2012
35. Senter L: Genetic testing by cancer site: Colon (nonpolyposis syndromes). Cancer J 18:334-337, 2012
36. Kastrinos F, Syngal S: Inherited colorectal cancer syndromes. Cancer J 17:405-415, 2011